Abstract：
Modern cardiac surgery has rapidly evolved to treat complex cardiovascular disease. This past year boasted noteworthy advances in xenotransplantation, prosthetic cardiac valves, and endovascular thoracic aortic repair. Newer devices often offer incremental design changes while demanding significant cost increases that leave surgeons to decide if the benefit to patients justifies the increased cost. As innovations are introduced, surgeons must continuously aim to harmonize short- and long-term benefits with financial costs). We must also ensure quality patient outcomes while embracing innovations that will advance equitable cardiovascular care.
摘要：
现代心脏手术已迅速发展到治疗复杂的心血管疾病。在过去的一年里，异种移植取得了显著的进展，人工心脏瓣膜,和胸主动脉腔内修复术。较新的设备通常会提供增量设计更改，同时要求显着增加成本，这让外科医生决定患者的利益是否证明成本增加是合理的。随着创新的引入，外科医生必须持续致力于协调短期和长期利益与财务成本)。我们还必须确保高质量的患者结果，同时拥抱将促进公平心血管护理的创新。
